Peer Review History: Remdesivir for the Treatment of COVID-19, its Safety and Clinical Effectiveness: A Clinical Review

Editor(s):

(1) Dr. Giuseppe Murdaca, University of Genoa, Viale Benedetto XV, n. 6, Genova 16132, Italy.

(2) Prof. Israa Faeck Jaafar, Al-esraa University College, Iraq.

Reviewers:

(1) Ali Adel Dawood, University of Mosul, Iraq.

(2) Haris Setyawan, Universitas Sebelas Maret, Indonesia.

(3) Prabhu K Halakatti, Bvvs Hanagal Shri Kumareshwar College of Pharmacy, India.

(4) Amisha Patel, Gayatri College of Pharmacy, India.

(5) Elizabeth Alejandrina Guzman Hernandez, Universidad Nacional Autónoma de México, Mexico.

Additional Reviewers:

 

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.2/10

Average Peer review marks at publication stage: 9/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (Ali Adel Dawood, Iraq) | File 1 | NA


Stage 2 | Peer review report_2 (Haris Setyawan, Indonesia) | File 1 | File 2


Stage 2 | Peer review report_3 (Prabhu K Halakatti, India) | File 1 | NA


Stage 2 | Peer review report_4 (Amisha Patel, India) | File 1 | NA


Stage 2 | Peer review report_5 (Elizabeth Alejandrina Guzman Hernandez, Mexico) | File 1 | NA


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA


Stage 3 | Comment_Editor_2_v1 | File 1 | NA


Posted in Review History.